Eminence Group Ventures - Eminence Business Media

Eminence Group Ventures - Eminence Business Media We conduct conferences, corporate-meetings, master-class training, seminars and workshops for Pharma.

We are the channel to connect the right set of people, the corporate bridge that connects knowledge, skills and business under one roof. We conduct conferences, corporate-meetings, master-class trainings, seminars, events and workshops, bringing expert speakers from across the world, personnel from superfluity of industries and service providers together and provide them content-rich and knowledge-packed sessions along with high level networking platforms.

24/06/2026

Strengthening Collaboration Between Pharma & CROs
Great partnerships don't happen by accident. They are built through clarity, communication, and shared accountability.
At the 6th Edition Drug Safety Symposium 2026 – India Chapter, Dr. Vipin Sethi is moderating an engaging discussion with Dr. Mangesh Kulkarni, Dr. Jamal Baig, and Dr. Gopal Muralidharan on how pharma companies and CROs are strengthening collaboration, improving governance models, and creating more effective pharmacovigilance ecosystems in an increasingly complex safety landscape.

eminencegroupventures

Inside the FDA Inspector's NotebookWhat are inspectors actually looking for?Dr. Abhay Chimankar is taking delegates insi...
24/06/2026

Inside the FDA Inspector's Notebook
What are inspectors actually looking for?
Dr. Abhay Chimankar is taking delegates inside the realities of pharmacovigilance inspections at the 6th Edition Drug Safety Symposium 2026 – India Chapter, sharing practical strategies to strengthen compliance, improve operational quality, and reduce the risk of common FDA observations before they become findings.

More data is arriving than ever before. The challenge is knowing what deserves attention.Dr. Kabil Kalathingal is taking...
24/06/2026

More data is arriving than ever before. The challenge is knowing what deserves attention.
Dr. Kabil Kalathingal is taking delegates through the opportunities and complexities of real-world evidence, digital channels, social media, and patient-generated data at the 6th Edition Drug Safety Symposium 2026 – India Chapter as the conversation shifts from data collection to identifying credible, actionable safety insights.Signal vs Noise: Filtering credible insights from fragmented, high-volume, structured and unstructured data sources

24/06/2026

The best ideas don't always come from presentations.

Meaningful conversations are taking shape across the room as partners, speakers and delegates connect during the structured networking session at the 6th Edition Drug Safety Symposium 2026 – India Chapter, exchanging experiences, discussing common challenges, and building relationships that extend well beyond the conference.

24/06/2026

Sometimes the biggest risks are not the ones we see. They are the pressures quietly building beneath the surface.
At the 6th Edition Drug Safety Symposium 2026 – India Chapter, Dr. Graeme Ladds is challenging conventional thinking around modern pharmacovigilance as growing case volumes, fragmented processes, increasing regulatory expectations, and operational complexity continue to test the resilience of safety systems worldwide.

24/06/2026

Global Regulatory Updates: Practical Implications for India
Regulations are evolving faster than ever. The real challenge is keeping operations aligned with them.

The regulatory panel is now underway at the 6th Edition Drug Safety Symposium 2026 – India Chapter, where Girish Bassavaraju is moderating a discussion featuring Dr. Rahul Somani, Dr. Devang Patel, Dr. Dharini Boopathi, and Dr. Mayuresh Kiran as they examine how global regulatory updates are influencing pharmacovigilance practices in India and what organizations need to prioritize to remain inspection-ready and future-focused.

From Reactive Compliance to Proactive OversightWhat if safety risks could be identified before they become safety issues...
24/06/2026

From Reactive Compliance to Proactive Oversight
What if safety risks could be identified before they become safety issues?
Sriram Varma is demonstrating how Agentic AI is supporting continuous oversight across safety, quality, compliance, and operational processes at the 6th Edition Drug Safety Symposium 2026 – India Chapter, helping organizations move beyond reacting to challenges and towards anticipating them before they impact patients or compliance.

24/06/2026

Patient safety doesn't end with pharmacovigilance.
Through the initiative, delegates at the 6th Edition Drug Safety Symposium 2026 – India Chapter are gaining hands-on exposure to CPR and emergency response techniques as Guneet Hayer leads a practical demonstration focused on responding effectively when every second matters.

Strengthening India's Pharmacovigilance Ecosystem: From Scale to ImpactIndia has built one of the world's largest pharma...
24/06/2026

Strengthening India's Pharmacovigilance Ecosystem: From Scale to Impact
India has built one of the world's largest pharmacovigilance databases. The question now is how to transform that scale into meaningful impact.
Dr. Nilima Kshirsagar is taking the stage at the 6th Edition Drug Safety Symposium 2026 – India Chapter, sharing perspectives on strengthening signal management, improving data quality, and ensuring that pharmacovigilance efforts continue to translate into better patient outcomes across the healthcare ecosystem.

Before we talk about drug saftey, PV ecosystem, and AI, it is worth asking a simpler question: Are we solving the challe...
24/06/2026

Before we talk about drug saftey, PV ecosystem, and AI, it is worth asking a simpler question: Are we solving the challenges that matter most?
Our Managing Director, Guneet Hayer, is welcoming the audience to the 6th Edition Drug Safety Symposium 2026 – India Chapter and sharing the vision behind this year's theme, "Beyond Algorithms & Assumptions, What Actually Matters in PV?"
As pharmacovigilance continues to evolve, the focus is shifting beyond tools and technology towards stronger decisions, clearer accountability, meaningful collaboration, and ultimately, better patient outcomes.

Address

Dubai Silicon Oasis, DDP
Dubai
BUILDINGA1

Opening Hours

Monday 09:30 - 18:00
Tuesday 09:30 - 18:00
Wednesday 09:30 - 18:00
Thursday 09:30 - 18:00
Friday 09:30 - 18:00
Saturday 09:30 - 14:00

Telephone

+971569011606

Alerts

Be the first to know and let us send you an email when Eminence Group Ventures - Eminence Business Media posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Eminence Group Ventures - Eminence Business Media:

Share